Business
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
Revenue from the Advanced Energy segment increased 6% in Q1 2025 compared with the same period last yearU.S. single use handpiece revenue grew 14% in Q1 2025 compared with the same period last yearPreparing for a planned launch of the AYON™ Body Contouring System in the second half of 2025, pending U.S. FDA clearanceManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”),
About this update from Apyx Medical Corporation
[{"type":"image","alt":"Apyx Medical Corporation","displaySize":"","headline":null,"caption":"Apyx Medical Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WNW7RVUw1wUG.ea_dTVO0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893","width":300,"height":157}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue from the Advanced Energy segment increased 6% in Q1 2025 compared with the same period last year","length":104,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. single use handpiece revenue grew 14% in Q1 2025 compared with the same period last year","length":93,"tagName":"p"}]},{"val":[{"type":"text","content":"Preparing for a planned launch of the AYON™ Body Contouring System in the second half of 2025, pending U.S. FDA clearance","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"Management to host a conference call today at 8:00 a.m. ET ","length":58,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":376,"olType":false},{"type":"text","content":"CLEARWATER, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today reported the financial results for its first quarter ended March 31, 2025.","length":322,"tagName":"p"},{"type":"text","content":"Recent Financial and Operating Highlights:","length":42,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reported total revenue of $9.4 million in the first quarter of 2025, compared to $10.2 million in the same period in the prior year.","length":132,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Advanced Energy revenue increased 6% to $7.9 million in the first quarter of 2025, compared to $7.5 million for the first quarter of 2024. This growth was driven primarily by strong generator unit sales and U.S. single-use handpiece sales.","length":239,"tagName":"p"}]},{"val":[{"type":"text","content":"OEM revenue of approximately $1.5 million, representing a decrease of ...